{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:27:12Z","timestamp":1751358432815},"reference-count":25,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/mco.2017.1228","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T12:33:22Z","timestamp":1493210002000},"page":"811-816","source":"Crossref","is-referenced-by-count":1,"title":["The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy"],"prefix":"10.3892","volume":"6","author":[{"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e5rd","family":"Manns\u00e5ker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Dalhaug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Pawinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellinor","family":"Haukland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"key20180107152409_b1-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijrobp.2013.06.2046","article-title":"How radiation oncologists evaluate and incorporate life expectancy estimates into the treatment of palliative cancer patients: A survey-based study","volume":"87","author":"Tseng","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152409_b2-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2012.05.047","article-title":"Predictors of survival in contemporary practice after initial radiosurgery for brain metastases","volume":"85","author":"Likhacheva","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152409_b3-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6601789","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer","volume":"90","author":"Forrest","year":"2004","journal-title":"Br J Cancer"},{"key":"key20180107152409_b4-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: A Glasgow Inflammation Outcome Study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107152409_b5-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","article-title":"A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study","volume":"47","author":"Proctor","year":"2011","journal-title":"Eur J Cancer"},{"key":"key20180107152409_b6-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clgc.2013.04.020","article-title":"Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy","volume":"11","author":"Linton","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"key20180107152409_b7-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.2012.45.0585","article-title":"Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States","volume":"31","author":"Guadagnolo","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107152409_b8-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1200\/JOP.2012.000835","article-title":"Patterns of care in palliative radiotherapy: A population-based study","volume":"9","author":"Murphy","year":"2013","journal-title":"J Oncol Pract"},{"key":"key20180107152409_b9-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1002\/cncr.27401","article-title":"Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer","volume":"118","author":"Kapadia","year":"2012","journal-title":"Cancer"},{"key":"key20180107152409_b10-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"6186543","DOI":"10.1155\/2016\/6186543","article-title":"Moving beyond Karnofsky and ECOG performance status assessments with new technologies","volume":"2016","author":"Kelly","year":"2016","journal-title":"J Oncol"},{"key":"key20180107152409_b11-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.prro.2014.06.003","article-title":"Choosing wisely: The American Society for Radiation Oncology's top 5 list","volume":"4","author":"Hahn","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"key20180107152409_b12-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ijrobp.2014.04.048","article-title":"Use of single- versus multiple-fraction palliative radiation therapy for bone metastases: Population-based analysis of 16,898 courses in a Canadian province","volume":"89","author":"Olson","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152409_b13-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","article-title":"Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients","volume":"77","author":"Sperduto","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152409_b14-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152409_b15-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijrobp.2012.06.009","article-title":"Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma","volume":"85","author":"Partl","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152409_b16-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00520-014-2385-y","article-title":"The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: A prospective cohort study","volume":"23","author":"Tan","year":"2015","journal-title":"Support Care Cancer"},{"key":"key20180107152409_b17-mco-0-0-1228","first-page":"1","article-title":"Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway","volume":"27","author":"Anshushaug","year":"2014","journal-title":"Acta Oncol"},{"key":"key20180107152409_b18-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JTO.0b013e318244ffe1","article-title":"Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer","volume":"7","author":"Leung","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20180107152409_b19-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: A comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107152409_b20-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3892\/ol.2012.722","article-title":"The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases","volume":"4","author":"Furukawa","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180107152409_b21-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.lungcan.2012.04.008","article-title":"The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer","volume":"77","author":"Gioulbasanis","year":"2012","journal-title":"Lung Cancer"},{"key":"key20180107152409_b22-mco-0-0-1228","first-page":"877","article-title":"Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy","volume":"34","author":"Angelo","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180107152409_b23-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/cncr.25112","article-title":"Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: Reality or myth?","volume":"116","author":"Gripp","year":"2010","journal-title":"Cancer"},{"key":"key20180107152409_b24-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3892\/ol.2015.3656","article-title":"Palliative radiotherapy during the last month of life: Predictability for referring physicians and radiation oncologists","volume":"10","author":"Nieder","year":"2015","journal-title":"Oncol Lett"},{"key":"key20180107152409_b25-mco-0-0-1228","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/cncr.28018","article-title":"Optimization of the systemic inflammation-based Glasgow prognostic score: A Glasgow Inflammation Outcome Study","volume":"119","author":"Proctor","year":"2013","journal-title":"Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T01:27:40Z","timestamp":1569115660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,26]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/mco.2017.1228"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1228","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}